Quantcast

Latest chemotherapy Stories

2014-06-30 23:16:32

There is new evidence that second-line chemotherapy with a drug called gemcitabine can significantly prolong survival in people with malignant pleural mesothelioma. Raleigh, NC (PRWEB) June 30, 2014 A new study out of Turkey finds that mesothelioma patients who have second-line chemotherapy with the antimetabolite, gemcitabine (Gemzar) had a median survival rate 8 months longer than those who had only first-line chemotherapy. Surviving Mesothelioma has just posted a report on the new...

2014-06-30 12:40:20

European Society for Medical Oncology ESMO 16 World GI Congress on Gastrointestinal Cancer For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer in Barcelona. "The CALGB/SWOG 80405 trial was designed and formulated in 2005, and the rationale was simple: we had new drugs --bevacizumab and cetuximab-- and the study...

2014-06-27 08:26:05

OAKLAND, Calif., June 27, 2014 /PRNewswire/ -- When friends asked Warren Keppler what he wanted out of fatherhood back in 2004, his answer came naturally: "I want to run with my girls." http://photos.prnewswire.com/prnvar/20130718/SF49717LOGO That time came on a bright and chilly Thanksgiving morning, when Warren and his 8-year-old daughter, Gabi, were nervously readying to run a race -- Gabi's first ever. As they waded through the crowd, Gabi, her hair tied back into a ponytail, took in...

2014-06-26 08:27:36

WOODCLIFF LAKE, N.J. and LUGANO, Switzerland, June 26, 2014 /PRNewswire/ -- Eisai Inc. and Helsinn Group announced today that several abstracts highlighting data analyses of NEPA, an investigational oral fixed-dose combination of netupitant and palonosetron being evaluated for the prevention of chemotherapy-induced nausea and vomiting (CINV), will be presented at the International Symposium on Supportive Care in Cancer. The Multinational Association of Supportive Care in...

2014-06-25 23:08:47

Transparency Market Research has published a new report titled "Global Liver Diseases Therapeutics Market: Industry Analysis, Size, Share, Trends and Forecast 2012 - 2018" to its report store. Browse the full report: http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html. Albany, New York (PRWEB) June 25, 2014 The report on “Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy And Immunosuppressants) - Global Industry...

2014-06-25 08:30:28

LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Triple Analysis: Leukemia, Lung Cancer and Melanomahttp://www.reportbuyer.com/pharma_healthcare/diseases/triple_analysis_leukemia_lung_cancer_melanoma.html This triple analysis focuses on cancer drug development strategies in Leukemia, Lung Cancer and Melanoma. Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment...

2014-06-24 11:15:22

Warwick University Research led by the University of Warwick’s Systems Biology Centre and Warwick Medical School in collaboration with groups in Nice and Rotterdam has been able to demonstrate how the cycle of cell division in mammalian cells synchronises with the body’s own daily rhythm, its circadian clock. The study not only helps to explain why people with sustained disrupted circadian rhythms can be more susceptible to cancer, it may also help establish the optimal time of day to...

2014-06-24 08:30:24

Using CyberKnife and chemotherapy, doctors treat primary and metastatic tumors FENTON, Mo., June 24, 2014 /PRNewswire/ -- When St. Louis CyberKnife patient Theresa Thompson was diagnosed with stage IV lung cancer, doctors determined the disease had spread beyond her lungs to her brain. http://photos.prnewswire.com/prnvar/20140623/120686 While stage IV lung cancer is difficult to treat, doctors reviewed her case and decided to aggressively treat with CyberKnife and chemotherapy....

2014-06-23 08:28:38

SAN ANTONIO, June 23, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, releases the updated corporate video explaining its lead drug candidate, G-202. The video explains, "The thapsigargin plant, a weed that grows abundantly in the Mediterranean, kills by disruption of the calcium balance in cells, all cells. Now, Genspera has targeted its active ingredient thapsigargin, to kill only the cells we select:...

2014-06-20 23:06:04

Italian researchers say a treatment made from a human protein can help improve the effectiveness of chemotherapy for patients fighting malignant pleural mesothelioma. Raleigh, NC (PRWEB) June 20, 2014 A team of cancer doctors says the combination of a lab-created compound based on a human protein and traditional chemotherapy drugs can help shrink mesothelioma tumors better than either treatment alone. Surviving Mesothelioma has just posted an article on the new research. Click here to...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »
Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related